J
Jérôme Vignat
Researcher at International Agency for Research on Cancer
Publications - 49
Citations - 11968
Jérôme Vignat is an academic researcher from International Agency for Research on Cancer. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 22, co-authored 35 publications receiving 8601 citations.
Papers
More filters
Journal ArticleDOI
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
Catherine de Martel,Jacques Ferlay,Silvia Franceschi,Jérôme Vignat,Freddie Bray,David Forman,Martyn Plummer +6 more
TL;DR: Application of existing public health methods for infection prevention, such as vaccination, safer injection practice, or antimicrobial treatments, could have a substantial effect on the future burden of cancer worldwide.
Journal ArticleDOI
European prospective investigation into cancer and nutrition (EPIC): study populations and data collection
Elio Riboli,Kelly J. Hunt,Nadia Slimani,Pietro Ferrari,Teresa Norat,Michael T. Fahey,Charrondière Ur,Bertrand Hémon,Corinne Casagrande,Jérôme Vignat,Kim Overvad,Anne Tjønneland,Françoise Clavel-Chapelon,Anne C. M. Thiébaut,Jürgen Wahrendorf,Heiner Boeing,Dimitrios Trichopoulos,Dimitrios Trichopoulos,Antonia Trichopoulou,Paolo Vineis,Domenico Palli,H. B. Bueno-De-Mesquita,Petra H.M. Peeters,Eiliv Lund,Dagrun Engeset,Carlos A. González,Aurelio Barricarte,Göran Berglund,Göran Hallmans,Nicholas E. Day,Timothy J. Key,Rudolf Kaaks,R. Saracci +32 more
TL;DR: The present paper provides a description of theEPIC study, with the aim of simplifying reference to it in future papers reporting substantive or methodological studies carried out in the EPIC cohort.
Journal ArticleDOI
Global burden of human papillomavirus and related diseases.
David Forman,Catherine de Martel,Charles J.N. Lacey,Isabelle Soerjomataram,Joannie Lortet-Tieulent,Laia Bruni,Jérôme Vignat,Jacques Ferlay,Freddie Bray,Martyn Plummer,Silvia Franceschi +10 more
TL;DR: Cervical cancer is the third most common female malignancy and shows a strong association with level of development, rates being at least four-fold higher in countries defined within the low ranking of the Human Development Index (HDI) compared with those in the very high category.
Journal ArticleDOI
Worldwide burden of cancer attributable to HPV by site, country and HPV type.
TL;DR: The preponderant burden of HPV16/18 and the possibility of cross‐protection emphasize the importance of the introduction of more affordable vaccines in less developed countries.
Journal ArticleDOI
Global burden of cancers attributable to infections in 2012: a synthetic analysis
Martyn Plummer,Catherine de Martel,Jérôme Vignat,ME Jacques Ferlay,Freddie Bray,Silvia Franceschi +5 more
TL;DR: A large potential exists for reducing the burden of cancer caused by infections, and population-based vaccination and screen-and-treat programmes should be made accessible and available.